| MeSH term | MeSH ID | Detail |
|---|---|---|
| Cerebral Infarction | D002544 | 6 associated lipids |
| Brain Ischemia | D002545 | 89 associated lipids |
| Cerebrovascular Disorders | D002561 | 25 associated lipids |
| Consciousness Disorders | D003244 | 2 associated lipids |
| Coronary Disease | D003327 | 70 associated lipids |
| Cystadenocarcinoma | D003536 | 3 associated lipids |
| Decerebrate State | D003655 | 7 associated lipids |
| Diabetes Mellitus | D003920 | 90 associated lipids |
| Distemper | D004216 | 1 associated lipids |
| Dysgerminoma | D004407 | 1 associated lipids |
4-hydroxy-butyric acid
4-hydroxy-butyric acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 8613 references associated with 4-hydroxy-butyric acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 4-hydroxy-butyric acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 4-hydroxy-butyric acid
PubChem Associated disorders and diseases
PubChem Biomolecular Interactions and Pathways
NCBI Entrez Crosslinks
All references with 4-hydroxy-butyric acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Vijay N and Morris ME | Effect of 3,4-methylenedioxymethamphetamine on the toxicokinetics and sedative effects of the drug of abuse, γ-hydroxybutyric acid. | 2014 | J Pharm Sci | pmid:25174723 |
| Johnson MW and Griffiths RR | Comparative abuse liability of GHB and ethanol in humans. | 2013 | Exp Clin Psychopharmacol | pmid:23421353 |
| Petersen IN et al. | Identification of a new metabolite of GHB: gamma-hydroxybutyric acid glucuronide. | 2013 | J Anal Toxicol | pmid:23612681 |
| Ingels AS et al. | Determination of gamma-hydroxybutyric acid in biofluids using a one-step procedure with "in-vial" derivatization and headspace-trap gas chromatography-mass spectrometry. | 2013 | J Chromatogr A | pmid:23664352 |
| Rosi L et al. | Determination of GHB and its precursors (GBL and 1,4-BD) in dietary supplements through the synthesis of their isotopologues and analysis by GC-MS method. | 2013 | J Pharm Biomed Anal | pmid:23245230 |
| Hawkins AS et al. | Role of 4-hydroxybutyrate-CoA synthetase in the CO2 fixation cycle in thermoacidophilic archaea. | 2013 | J. Biol. Chem. | pmid:23258541 |
| Munshi T et al. | Monitoring of the interconversion of gamma-butyrolactone (GBL) to gamma hydroxybutyric acid (GHB) by Raman spectroscopy. | 2013 | Drug Test Anal | pmid:23225646 |
| Amer B et al. | Novel GHB-derived natural products from European mistletoe (Viscum album). | 2013 | Pharm Biol | pmid:23734579 |
| de Jong CA et al. | Treatment of GHB withdrawal syndrome: Catch 22 or challenge for addiction medicine? | 2013 | Addiction | pmid:23718746 |
| Choi S et al. | Production of 4-hydroxybutyric acid by metabolically engineered Mannheimia succiniciproducens and its conversion to γ-butyrolactone by acid treatment. | 2013 | Metab. Eng. | pmid:24055777 |